| Prognostic role of myeloid-derived suppressor cells in cancers: a systematic review and meta-analysis L Ai, S Mu, Y Wang, H Wang, L Cai, W Li, Y Hu BMC cancer 18, 1-9, 2018 | 112 | 2018 |
| Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID‐19 patients: a multicenter retrospective study JY Li, HF Wang, P Yin, D Li, DL Wang, P Peng, WH Wang, L Wang, ... Journal of Thrombosis and Haemostasis 19 (4), 1038-1048, 2021 | 69 | 2021 |
| Prognostic Value of Neutrophil to Lymphocyte Ratio for In-hospital Mortality in Elderly Patients with Acute Myocardial Infarction YB Guo T, Cheng B, Ke L, Guan S, Qi B, Li W Curr Med Sci 38 (2), 354-359, 2018 | 38 | 2018 |
| TNF‐α Upregulates Fgl2 Expression in Rat Myocardial Ischemia/Reperfusion Injury P Jia, J Wang, L Wang, X Chen, Y Chen, WZ Li, R Long, J Chen, YW Shu, ... Microcirculation 20 (6), 524-533, 2013 | 32 | 2013 |
| The significance of microthrombosis and fgl2 in no-reflow phenomenon of rats with acute myocardial ischemia/reperfusion L Shao, D Wu, P Zhang, W Li, J Wang, G Su, Y Liao, Z Wang, K Liu Clinical and Applied Thrombosis/Hemostasis 19 (1), 19-28, 2013 | 31 | 2013 |
| Time-restricted salutary effects of blood flow restoration on venous thrombosis and vein wall injury in mouse and human subjects W Li, CW Kessinger, M Orii, H Lee, L Wang, I Weinberg, MR Jaff, GL Reed, ... Circulation 143 (12), 1224-1238, 2021 | 26 | 2021 |
| Sodium tanshinone IIA sulfonate ameliorates experimental coronary no-reflow phenomenon through down-regulation of FGL2 R Long, Y You, W Li, N Jin, S Huang, T Li, K Liu, Z Wang Life sciences 142, 8-18, 2015 | 21 | 2015 |
| Fibrinogen-like protein 2 expression correlates with microthrombosis in rats with type 2 diabetic nephropathy G Su, K Liu, Y Wang, J Wang, X Li, W Li, Y Liao, Z Wang Journal of biomedical research 25 (2), 120-127, 2011 | 18 | 2011 |
| FGL2 prothrombinase contributes to the early stage of coronary microvascular obstruction through a fibrin-dependent pathway WZ Li, Y Yang, K Liu, R Long, N Jin, SY Huang, Y You, J Dai, C Fan, ... International journal of cardiology 274, 27-34, 2019 | 16 | 2019 |
| Atorvastatin preconditioning improves the forward blood flow in the no‐reflow rats L Shao, Y Zhang, A Ma, P Zhang, D Wu, W Li, J Wang, K Liu, Z Wang Fundamental & clinical pharmacology 28 (1), 42-52, 2014 | 15 | 2014 |
| The FGL2 prothrombinase contributes to the pathological process of experimental pulmonary hypertension C Fan, J Wang, C Mao, W Li, K Liu, Z Wang Journal of Applied Physiology 127 (6), 1677-1687, 2019 | 13 | 2019 |
| Novel antibody against a glutamic acid-rich human fibrinogen-like protein 2-derived peptide near Ser91 Inhibits hfgl2 prothrombinase activity WZ Li, J Wang, R Long, GH Su, DK Bukhory, J Dai, N Jin, C Fan, K Liu, ... PloS one 9 (4), e94551, 2014 | 11 | 2014 |
| In Vivo Platelet Detection Using a Glycoprotein IIb/IIIa-Targeted Near-Infrared Fluorescence Imaging Probe K Ha, X Zheng, CW Kessinger, A Mauskapf, W Li, Y Kawamura, M Orii, ... ACS sensors 6 (6), 2225-2232, 2021 | 10 | 2021 |
| Role of Kv1. 3 channels in platelet functions and thrombus formation C Fan, X Yang, WW Wang, J Wang, W Li, M Guo, S Huang, Z Wang, K Liu Arteriosclerosis, Thrombosis, and Vascular Biology 40 (10), 2360-2375, 2020 | 10 | 2020 |
| Mechanism of liver fibrosis and its progress on the latest therapeutic drugs. HB Chen, W Wu, WZ Li, GY Hu Journal of Clinical and experimental Medicine (China). 7 (2), 164-165, 2008 | 10* | 2008 |
| Intravascular molecular‐structural imaging with a miniaturized integrated near‐infrared fluorescence and ultrasound catheter S Kellnberger, G Wissmeyer, M Albaghdadi, Z Piao, W Li, A Mauskapf, ... Journal of biophotonics 14 (10), e202100048, 2021 | 4 | 2021 |
| Relationship between coronary microvascular dysfunction and adverse ventricular remodeling after myocardial infarction. ZH Wang, WZ Li Journal of Clinical Cardiology (China) 31 (7), 693-695, 2015 | 3* | 2015 |
| Review of current therapeutic drugs for anti-liver fibrosis. HB Chen, W Wu, W Li, A Leng China Pharmacy. 19 (13), 1021-1023, 2008 | 3* | 2008 |
| SVM Communications: Venous Taskforce update and Society announcements ST Ahsan, O Esponda, W Li, R Amini, M Shaydakov, J Wheeler, E Fukaya Vascular Medicine 28 (5), 493-495, 2023 | | 2023 |
| The Role of Supervised Exercise Therapy in the Management of Symptomatic Peripheral Artery Disease with Intermittent Claudication FQ Wu, QW Deng, JG Wang, WZ Li Current Treatment Options in Cardiovascular Medicine 25 (10), 501-513, 2023 | | 2023 |
Farouc JafferMassachusetts General Hospital, Harvard Medical SchoolПодтвержден адрес электронной почты в домене mgh.harvard.edu
